The key role of HGF/SF-MET signalling in metastasis has propelled MET among the top targets for human cancer therapy23 and substantial progress has been made in recent years in developing inhibitors of the MET kinase and antibodies directed to HGF/SF or the MET ectodomain. The gene discussed is MET; the disease is cancer.